Avalyn Pharma raises $100 million in a Series D round to develop inhaled medicines for pulmonary fibrosis, targeting effective delivery to the lungs.
Amount Raised
$100 Million
Round Type
Series D
SeattleBiotechnologyHealthcareHealth CareInvestors
Description
Avalyn Pharma has secured $100 million in a Series D funding round. The funding will be used to advance their inhaled pulmonary fibrosis medicines. The company aims to ensure the drugs reach the optimal location within the lung for effectiveness. This investment marks a significant step in their development process.
Quick answer
Avalyn raised $100 Million in a Series D round, dated July 22, 2025. Investors: Wellington Management, T. Rowe Price Associates, Catalio Capital Management, SR One and Suvretta Capital Management. Avalyn is based in Seattle, Washington, United States.
- How much did Avalyn raise?
- Avalyn raised $100 Million in a Series D round on July 22, 2025.
- Who invested in Avalyn?
- Wellington Management, T. Rowe Price Associates, Catalio Capital Management, SR One and Suvretta Capital Management are named as investors in this round.
- What does Avalyn do?
- Avalyn is reimagining the future of pulmonary fibrosis treatment, with a pipeline of new inhaled formulations of approved medicines.
- Where is Avalyn based and how big is it?
- Avalyn is based in Seattle, Washington, United States. Fundz records about 49 employees.
- Who are the decision-makers at Avalyn?
- Fundz holds 3 contacts at Avalyn. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Avalyn that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $3.8M on September 2, 2025.
- CHARM Therapeutics raised $80M (Series B) on September 2, 2025.
- Enlaza Therapeutics raised $15M on August 29, 2025.
- Immuneering raised $25M on August 26, 2025.
- QurAlis raised $20M on August 21, 2025.
- CHARM Therapeutics raised $17M on August 19, 2025.
Who to call at Avalyn, and when
A new round usually means Avalyn is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Avalyn raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Avalyn, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Avalyn. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Avalyn raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Avalyn raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.